by EmVenio | Aug 20, 2024 | Blog
Source Kansas City Business Journal Aug 13, 2024 03:07 PM CDTAuthor Grace MayerA metro-area Prime Healthcare hospital will play a part in bolstering nationwide access to clinical trials. EmVenio Research’s new center will go inside Providence...
by EmVenio | Aug 14, 2024 | Blog
The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s...
by EmVenio | Jun 6, 2024 | Blog
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site...
by EmVenio | May 31, 2024 | Blog
Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the...
by EmVenio | Apr 15, 2024 | Blog
The recent World Vaccine Congress proved to be a pivotal moment for the industry, marking achievements, recognition, and inspiring discussions that propel us forward in the realm of clinical trials and vaccine development. As we gather our thoughts and reflections,...
by EmVenio | Mar 26, 2024 | Blog
Over the past few months, EmVenio has led a series of impactful events in Alabama, Illinois, and Florida, to boost community well-being. These local connections raise awareness about the importance of clinical research and offer local residents the opportunity to...
